BERLIN, 16 October 2023– Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), announced a partnership at the World Health Summit today to accelerate the use of artificial intelligence (AI) in X-ray screening for tuberculosis (TB), a preventable, treatable, and curable infectious disease that is again on the rise globally.

A new study from the University of Pittsburgh Center for Vaccine Research published in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.

An increased risk for TB recurrence/relapse was associated with ever smoking (RR, 1.78), current smoking (RR, 1.95), and past smoking (RR, 1.84) vs never smoking.

Kenya is likely to lose gains made in the fight against TB, a leading infectious disease, following an acute shortage of drugs.

During the January-March 2023 quarter, that is, after a year’s implementation of TN-KET project in Tamil Nadu, India nine out of 30 TB districts showed at least 20-30% TB death rate reduction among patients diagnosed when compared to the baseline. An article, published in IndiaSpend, discusses what differentiated TB care means and why it is essential to be implemented as part of the national TB program in India.

Pharmaceutical giant Johnson & Johnson (J&J) recently announced that it would lift patents on the life-saving drug bedaquiline.

Adding dexamethasone to treatment for tuberculous (TB) meningitis among heavily immunosuppressed HIV-positive patients in a low-resource setting did not significantly improve survival or confer any other measured benefits, a randomized controlled trial showed.

A study led by scientists at University of St Andrews has found that antibiotics used to treat tuberculosis kill other potentially useful bacteria.

The National Tuberculosis Elimination Programme (NTEP) has included Serum-Mylab’s indigenously developed latent test to detect tuberculosis to further its effort to eliminate the infectious disease by 2025.

Treatment Action Group launches the first TB chapter of its 2023 Pipeline Report.